In a recent study, two AITL cases were analyzed using multiplexed quantitative immunohistochemistry techniques and one panel to simultaneously stain for a collection of relevant markers in lymphoid tissue to determine the expression of marker of interest in malignant cells, such as the CD4, PD-1, and BCL6. The gene discussed is CD4; the disease is angioimmunoblastic T-cell lymphoma.